David O’Neill

Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

Dusan Bogunovic, David O’Neill, Ilana Belitskaya‐Lévy et al. · Proceedings of the National Academy of Sciences · 2009 · 381 citations

Medicine, Immunology, Oncology +17

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

Danila Valmori, Naira E. Souleimanian, Valeria Tosello et al. · Proceedings of the National Academy of Sciences · 2007 · 295 citations · Full text

Medicine, Immunology, Oncology +17

Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant

Sylvia Adams, David O’Neill, Daisuke Nonaka et al. · The Journal of Immunology · 2008 · 245 citations · Full text

Medicine, Immunology, Oncology +17

An Ikaros-Containing Chromatin-Remodeling Complex in Adult-Type Erythroid Cells

David O’Neill, Stuti Schoetz, Rocío López et al. · Molecular and Cellular Biology · 2000 · 165 citations

Life Sciences, Genetics, Molecular Biology +14

Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors.

Elsa F. Velázquez, Achim A. Jungbluth, Molly Yancovitz et al. · PubMed · 2007 · 114 citations · Full text

Medicine, Immunology, Oncology +17